Life sciences briefing: Tuesday, Jan. 29, 2008
TODAY’S HEADLINES:
Immune-system specialty pharma Circassia raises £11M (release)
Cancer-biomarker biotech CS-Keys takes in $6.3M (release)
Neuro-robotic device maker Myomo receives $3M (VentureWire)
Micropharma draws C$1.8M for nutraceutical delivery (VentureWire)
Avalon Labs gets $66M for disposable life-support components (release)
Gloucester Pharma names Alan Colowick as CEO (release)
ConforMIS names Philipp Lang as… Continue Reading
Akermin raises $5M for fuel-cell bioenzymes
NOTE: This item also appears in Monday’s daily briefing at VentureBeat Life Sciences.
Akermin, a St. Louis developer of new biocatalytic enzymes, raised $5 million in a second tranche of its first funding round. Investors included Prolog Ventures, OnPoint Technologies, Chrysalix Energy and the St. Louis Arch… Continue Reading
Life sciences briefing: Tuesday, Nov. 13, 2007
Featured companies: Akermin, Fluxion Biosciences, iCardiacTechnologies, Wellocities
UPDATED: Expanded items on Fluxion, Akermin, and Wellocities.
Fluxion Bio draws in $6.9M for cell-analysis tools — Fluxion Biosciences, a San Francisco developer of cellular-analysis tools, raised $6.9 million in a second funding round, VentureWire reports (subscription required). Investors included Kodiak Venture… Continue Reading
LightFull Foods raises $1M more for health beverages
San Francisco-based health beverage company LightFull Foods raised an extra $1 million in addition, adding to the $6.1 million second round of financing it recently raised last year.
Burrill & Co. led the latest investment, which included Prolog Ventures, Palo Alto Investors, Great Spirit Ventures, Unilever… Continue Reading
Life sciences briefing: Wednesday, Sept. 19, 2007
Featured companies: Acceleron Pharma, AdvanDx, Altheus Therapeutics, BiPar Sciences, Coventina Healthcare Enterprises, ForteBio, Ganymed Pharmaceuticals, Mako Surgical, Nile Therapeutics, Novate Medical
[NOTE: This briefing was posted on Friday, 9/21/07; I've edited its timestamp to preserve chronological order among the briefings.]
Nile Therapeutics raises $20M, goes public in reverse… Continue Reading
Biomarker-diagnostics developer Singulex validates $19M
Hayward, Calif.-based Singulex, a developer of sensitive molecular-detection systems, raised $19 million in a fourth funding round. The company’s release is here.
The company is developing an analysis system, called Erenna, plus related “assays,” or specially designed biochemical tests, that are designed to detect individual protein… Continue Reading
Attune Foods raises $8.3M to expand probiotics natural food venture
Attune Foods, a San Francisco natural foods company, said it has secured $8.3 million in a second round of funding.
New investors include Fonterra, LSP BioVentures and Nestlé, along with original investors Burrill & Company, Great Spirit Ventures, Prolog Ventures and Unilever Ventures, the company… Continue Reading